Lee Altus, Steve “Zetro” Souza, and Kragen Lum of Exodus perform onboard the cruise liner “Independence of the Seas” during ...

Advances in clinical development keep the hope alive of having new drugs in the not-so-distant future to complement ... for ...

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access ... patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

Deepening isolation: Substance use tends to strain existing relationships and inhibit the formation of new ones, creating a ...

Since this observation was published in the early 2000s, ketamine clinics, where the drug is administered intravenously to ... Moreover, the increase in excitation initiates the formation of new or ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

When active filaments are exposed to localized illumination, they accumulate into stable structures along the boundaries of ...

Scientists uncovered a previously unrecognized tumor suppression mechanism through the study of condensates and ribosome formation.

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.

From the formation of inner ear bones to the rise of hair to cover our bodies, these developments made us distinct from other ...

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...